These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6850570)

  • 41. Relationship of urinary N-butyl-N-(3-carboxypropyl)nitrosamine to susceptibility of animals to bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Suzuki E; Mochizuki M; Okada M
    Gan; 1983 Jun; 74(3):360-4. PubMed ID: 6884694
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhancement by phenothiazine and 2,5-di-O-acetyl-D-glucosaccharo-(1,4)(6,3)-dilactone of bladder carcinogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide in rats.
    Wang CY; Hayashida S
    Cancer Lett; 1984 Aug; 24(1):37-43. PubMed ID: 6548659
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of L-tryptophan and sodium saccharin on urinary tract carcinogenesis initiated by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Fukushima S; Friedell GH; Jacobs JB; Cohen SM
    Cancer Res; 1981 Aug; 41(8):3100-3. PubMed ID: 7248968
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of avitaminosis A and hypervitaminosis A on urinary bladder carcinogenicity of N-(4-(5-Nitro-2-furyl)-2-thiazolyl)formamide.
    Cohen SM; Wittenberg JF; Bryan GT
    Cancer Res; 1976 Jul; 36(7 PT 1):2334-9. PubMed ID: 1277139
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synergistic effect of urinary bladder carcinogenesis in rats treated with N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide,N-2-fluorenylacetamide, and 3,3'-dichlorobenzidine.
    Tsuda H; Miyata Y; Murasaki G; Kinoshita H; Fukushima S
    Gan; 1977 Apr; 68(2):183-92. PubMed ID: 892292
    [No Abstract]   [Full Text] [Related]  

  • 46. Potentiation of 1-2-dimethylhydrazine-induced bowel carcinogenesis by the urinary bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Steele G; Chrissey M; Gittes R; Corson J; Wilson R
    Carcinogenesis; 1980 Feb; 1(2):135-8. PubMed ID: 22282992
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Agglutination by concanavalin A of urothelial cells of heterotropically transplanted rat urinary bladders: effect of bladder carcinogens and urine.
    Homma Y; Ozono S; Wallenmark CB; Oyasu R
    Carcinogenesis; 1985 Jul; 6(7):1059-61. PubMed ID: 4017172
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-promoting effect of nordihydroguaiaretic acid on N-butyl-N-(4-hydroxybutyl)nitrosamine and sodium saccharin-induced rat urinary bladder carcinogenesis.
    Yu A; Hashimura T; Nishio Y; Kanamaru H; Fukuzawa S; Yoshida O
    Jpn J Cancer Res; 1992 Sep; 83(9):944-8. PubMed ID: 1429204
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 13-cis-retinoic acid: effect on urinary bladder carcinogenesis by N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide in Fischer rats.
    Croft WA; Croft MA; Paulus KP; Williams JH; Wang CY; Lower GM
    Cancer Lett; 1981 May; 12(4):355-60. PubMed ID: 6946855
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Summation effects of uracil and other promoters on epithelial lesion development in the F344 rat urinary bladder initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    de Camargo JL; Shirai T; Kato T; Asamoto M; Fukushima S
    Jpn J Cancer Res; 1991 Nov; 82(11):1220-5. PubMed ID: 1752781
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Strain differences in sensitivity to the promoting effect of sodium L-ascorbate in a two-stage rat urinary bladder carcinogenesis model.
    Murai T; Mori S; Hosono M; Takashima A; Machino S; Oohara T; Yamashita H; Makino S; Matsuda T; Wanibuchi H; Fukushima S
    Jpn J Cancer Res; 1997 Mar; 88(3):245-53. PubMed ID: 9140108
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative assessments of the cytotoxicity of bladder carcinogens towards cultured normal human uroepithelial cells.
    Reznikoff CA; Loretz LJ; Johnson MD; Swaminathan S
    Carcinogenesis; 1986 Oct; 7(10):1625-32. PubMed ID: 3757166
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of the effects of cotinine and nicotine-N'-oxides on the development of tumors in rats initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    LaVoie EJ; Shigematsu A; Rivenson A; Mu B; Hoffmann D
    J Natl Cancer Inst; 1985 Dec; 75(6):1075-81. PubMed ID: 3865011
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Promoting effects of dimethylarsinic acid on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in rats.
    Wanibuchi H; Yamamoto S; Chen H; Yoshida K; Endo G; Hori T; Fukushima S
    Carcinogenesis; 1996 Nov; 17(11):2435-9. PubMed ID: 8968060
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Salim EI; Wanibuchi H; Morimura K; Kim S; Yano Y; Yamamoto S; Fukushima S
    Carcinogenesis; 2000 Feb; 21(2):195-203. PubMed ID: 10657958
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The pathogenesis of experimental bladder cancer.
    Bryan GT
    Cancer Res; 1977 Aug; 37(8 Pt 2):2813-6. PubMed ID: 326392
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The influence of antipyrene on N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induced urinary tract carcinogenesis.
    Johansson SL; Anderström C
    Carcinogenesis; 1988 May; 9(5):783-7. PubMed ID: 3365839
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The lithium carbonate promotion of urothelial tumors in rats induced with N-butyl-N-(4-hydroxybutyl)-nitrosamine].
    Frolov AG; Pliss GB
    Vopr Onkol; 1992; 38(11):1309-13. PubMed ID: 1343160
    [TBL] [Abstract][Full Text] [Related]  

  • 59. H-ras mutations in rat urinary bladder carcinomas induced by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and sodium saccharin, sodium ascorbate, or related salts.
    Masui T; Mann AM; Macatee TL; Okamura T; Garland EM; Fujii H; Pelling JC; Cohen SM
    Cancer Res; 1991 Jul; 51(13):3471-5. PubMed ID: 2054786
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Promotion by ascorbic acid, sodium erythorbate and ethoxyquin of neoplastic lesions in rats initiated with N-butyl-N-(4-hydroxybutyl) nitrosamine.
    Fukushima S; Kurata Y; Shibata M; Ikawa E; Ito N
    Cancer Lett; 1984 May; 23(1):29-37. PubMed ID: 6744233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.